Journal of the American College of Cardiology

Papers
(The H4-Index of Journal of the American College of Cardiology is 110. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–20194371
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up2097
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic1273
Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic876
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease827
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure766
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19729
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction576
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization541
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary519
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection516
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement507
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research417
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy362
The Global Burden of Cardiovascular Diseases and Risk359
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19356
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation340
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain328
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary311
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19303
Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations300
Preeclampsia—Pathophysiology and Clinical Presentations298
Worldwide Prevalence of Familial Hypercholesterolemia297
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic285
Characterization of Myocardial Injury in Patients With COVID-19285
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction270
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes269
Virtual Learning During the COVID-19 Pandemic266
The Global Burden of Cardiovascular Diseases and Risks264
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic244
Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation244
Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease240
The NCDR Left Atrial Appendage Occlusion Registry230
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care227
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19222
2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Pl217
Management of Acute Myocardial Infarction During the COVID-19 Pandemic216
Spontaneous Coronary Artery Dissection210
Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy209
SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies207
High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction206
Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality206
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease205
Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation201
Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases201
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation199
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk198
The ARIC (Atherosclerosis Risk In Communities) Study192
Machine Learning and the Future of Cardiovascular Care189
Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy187
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants187
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis184
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage184
Echocardiographic Findings in Pediatric Multisystem Inflammatory Syndrome Associated With COVID-19 in the United States177
Wearable Devices for Ambulatory Cardiac Monitoring177
Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis173
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction170
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women170
Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China168
Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation167
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy167
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves162
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease158
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia155
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy155
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk153
Heart Failure With Recovered Left Ventricular Ejection Fraction151
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19150
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk148
Cardiovascular Deaths During the COVID-19 Pandemic in the United States147
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia146
Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis146
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI144
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary144
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19143
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary143
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients143
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or Wi141
Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation140
Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients138
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement138
Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies137
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction134
Management of Hypertrophic Cardiomyopathy129
International Impact of COVID-19 on the Diagnosis of Heart Disease128
2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation128
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis127
Pathophysiology of Takotsubo Syndrome126
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study126
Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis124
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy122
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque122
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease119
Antithrombotic Therapy for Patients With Left Ventricular Mural Thrombus118
Presentation and Outcome of Arrhythmic Mitral Valve Prolapse118
Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S.118
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction118
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy116
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial116
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System116
Ticagrelor With or Without Aspirin After Complex PCI115
Global Chronic Total Occlusion Crossing Algorithm113
Atrial Fibrillation113
Interventions for Frailty Among Older Adults With Cardiovascular Disease113
Challenges in Cardiac and Pulmonary Sarcoidosis113
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation113
Inflammation, Aging, and Cardiovascular Disease113
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure113
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial112
Prevalence and Prognostic Significance of Malnutrition in Patients With Acute Coronary Syndrome111
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease110
Smartphone Activation of Citizen Responders to Facilitate Defibrillation in Out-of-Hospital Cardiac Arrest110
Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction110
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial110
0.039863109588623